Ultrasound therapy developer Theraclion announced that more than 1 million Germans are now covered for echotherapy to treat breast fibroadenomas, the most common form of benign breast lesions.
Delivered with the company's Echopulse system, echotherapy combines high-intensity focused ultrasound (HIFU) and ultrasound imaging for noninvasive treatment of tumors, monitored in real-time.
Since September 2014, three Betriebskrankenkassen (BKK) health insurance companies have covered echotherapy and two more joined this month, bringing the total to five insurance companies and more than 1 million covered patients eligible to receive reimbursed echotherapy treatment in Germany, Theraclion said.
